# Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China

> **NCT01340950** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 250 (actual)

## Conditions studied

- HIV Infections
- Central Nervous System Diseases
- Dementia

## Interventions

- **DRUG:** zidovudine-lamivudine-nevirapine
- **DRUG:** tenofovir-lamivudine-efavirenz

## Key facts

- **NCT ID:** NCT01340950
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-07
- **Final completion:** 2015-07
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2016-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01340950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01340950, "Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01340950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*